SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-24-029940
Filing Date
2024-04-03
Accepted
2024-04-03 17:27:41
Documents
4
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea0203241-pre14a_cerothera.htm PRE 14A 512686
2 GRAPHIC image_001.jpg GRAPHIC 3515
3 GRAPHIC image_002.jpg GRAPHIC 929239
4 GRAPHIC image_003.jpg GRAPHIC 555522
  Complete submission text file 0001213900-24-029940.txt   2563841
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40877 | Film No.: 24820251
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)